Roquefort Therapeutics (LON:ROQ) Trading Down 1.1%

Shares of Roquefort Therapeutics plc (LON:ROQ) were down 1.1% during trading on Thursday . The company traded as low as GBX 4.50 ($0.06) and last traded at GBX 4.50 ($0.06). Approximately 332,329 shares traded hands during trading, an increase of 4% from the average daily volume of 319,000 shares. The stock had previously closed at GBX 4.55 ($0.06).

Roquefort Therapeutics Stock Down 1.1 %

The firm has a fifty day moving average of GBX 6.87 and a 200-day moving average of GBX 6.97. The stock has a market capitalization of £5.81 million, a price-to-earnings ratio of -381.25 and a beta of -0.03.

About Roquefort Therapeutics

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.